Drug intelligence / Profile preview

Phyto Nova Sutherlandia Gel

Development stage
Discontinued
Lead developer
PhytoNova
Administration
Topical
01

Overview

Phyto Nova Sutherlandia Gel is a topical herbal preparation developed by Phyto Nova, a South African company specializing in indigenous plant medicines. The gel contains a 20% m/v extract of *Sutherlandia frutescens*, a plant native to South Africa with a long history of traditional medicinal use. It is formulated to provide soothing relief for symptoms associated with inflammatory skin conditions, including eczema and psoriasis. The product is reported to possess anti-inflammatory, anti-oxidant, analgesic, and anti-bacterial properties. Classified as a complementary medicine rather than a pharmaceutical drug, it was not evaluated by the South African Medicines Control Council. The developer, Phyto Nova Pty Ltd, has since been dissolved, and the product is no longer actively marketed.

Brand names
Phyto Nova Sutherlandia Gel
Other names
Sutherlandia Gel
02

Targets

CYP2C19 (Cytochrome P450 2C19)OATP1B1 (Organic anion transporting polypeptide 1B1)CYP1A2 (Cytochrome P450 1A2)ABCB1 (P-glycoprotein)SLCO1B3 (Organic anion transporting polypeptide 1B3)CYP2B6 (Cytochrome P450 2B6)CYP2C9 (Cytochrome P450 family 2 subfamily C member 9)CYP2C8 (Cytochrome P450 2C8)CYP2A6 (Cytochrome P450 2A6)

Beyond the preview

Go deeper on Phyto Nova Sutherlandia Gel.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phyto Nova Sutherlandia Gel.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call